<DOC>
	<DOCNO>NCT01358695</DOCNO>
	<brief_summary>The purpose study provide evidence safety , tolerance , efficacy ANT-1207 treatment Crow 's Feet .</brief_summary>
	<brief_title>Clinical Trial To Evaluate ANT-1207 In Subjects With Crow 's Feet</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>mild moderate Crow 's Feet wrinkle ( IGA 23 ) rest moderate severe Crow 's Feet ( IGA 34 ) contraction willingness refrain product affect skin remodel female subject must pregnant nonlactating history periocular surgery , brow lift related procedure procedure affect lateral canthal region prior 12 month application topical prescription medication treatment area female subject pregnant nursing child</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Lateral Canthal Lines</keyword>
	<keyword>Crow 's Feet</keyword>
</DOC>